Arkolith/Insider Trading/BCRX/Form 4

Heggie Theresa

DirectorBIOCRYST PHARMACEUTICALS INC (BCRX) · full profile →Form 4 · filed Aug 15, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$596K
Net Open-Market Flow
-$596K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2025Sell(S)70K$8.51$596K65K
Aug 13, 2025Option exercise(M)40K$5.41$216K135K
Aug 13, 2025Option exercise(M)30K$2.91$87K95K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 13, 2025Option exercise(M)40K—$00
Aug 13, 2025Option exercise(M)30K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-25-020491) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML